This acquisition also provides CBSC and its subsidiary My-Cardia (USA) Inc. BriefingWire.com, 12/29/2020 - Established Suppler of FDA and CE Cleared EKG Devices and Software. Expert Management Including CEO from a Top Industry Leader. Targeting Worldwide Market Share Growth Through Acquisitions. New Operations in Thailand Recently Commenced. CB Scientific, Inc. (OTC: CBSC), through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring field. The CBSC FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.